S.M.A.R.T. Radianz Vascular Stent System approved for transradial use in the U.S.
It signals Cordis' renewed investment in innovation
It signals Cordis' renewed investment in innovation
Lynparza is approved in the US, EU, Japan and several other countries for the treatment of patients with gBRCAm, HER2-negative, metastatic breast cancer previously treated with chemotherapy based on results from the OlympiAD Phase III trial
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Tislelizumab is now approved for seven indications in China
Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
Data from this study will support a submission to expand the use of atogepant to include preventive treatment of chronic migraine in the United States and additional submissions globally
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
Paxlovid is the first oral therapy specifically designed to combat Covid-19 to be evaluated in a pediatric clinical study
It is also setting up laboratories in West Bengal, Assam, Bihar, Jharkhand and Orissa to comprehensively cater to the East India region
Subscribe To Our Newsletter & Stay Updated